You already know that we’re not all alike, and this also applies to the way we metabolize medicines. Some people metabolize a medicine quickly, and then it affects them too strongly because of the speed at which it’s metabolized. Other people metabolize unusually slowly, leaving some of the medication unabsorbed, so that it fails to deliver the full strength the doctor intended.
With improper dosing for genotype, there is also the risk of ADRs—Adverse Drug Reactions—which can be very serious and even deadly.
PGX testing can tell a doctor whether his/her patient metabolizes meds unusually slowly, quickly, or at a normal rate, and can help predict and therefore prevent ADRs.
Every year, over 8 million—almost 9 million—ADRs occur to patients, and over 2 million of these are severe.
Did you know that only heart disease, cancer and stroke cause more deaths nationwide than ADRs? That’s right—ADRs are the fourth leading cause of death in our country!
PGX tests can predict how a patient will metabolize a drug and allow the prescriber to tailor the dose accordingly—to not only ensure maximum efficacy of the medication but prevent ADRs. And not only does this lower risks, it lowers health care costs as well.
This applies to many types of drugs, used in the care and management of cardiovascular health, mental/emotional health (neuropsychiatry), orthopedics (where, for example, we can identify inherited coagulation pathway deficits that increase the risk of thrombosis, as well as issues with excessive bleeding or non-responsiveness to post-op pain meds), and pain management.